comparemela.com
  1. Home
  2. Live Updates
  3. About Synaptogenix - Breaking News

Latest Breaking News On - About synaptogenix - Page 1 : comparemela.com

Synaptogenix Announces Publication of Peer-Reviewed Scientific Article Evidencing Byrostatin-1 s Improved Cognition Over Baseline in Advanced Alzheimer s Disease Patients

/PRNewswire/ Synaptogenix, Inc. (Nasdaq: SNPX) ("the Company"), a clinical-stage biopharmaceutical company developing regenerative therapeutics for.

Robert weinsteinExchange commissionDrug administrationPrnewswire synaptogenix incSynaptogenix incAdvanced alzheimerAbout synaptogenixHealth supported phaseOrphan drug designationMedia contact

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.